ACT-Accelerator公布313亿美元投资计划应对COVID-19

世界卫生组织下属的ACT-Accelerator全球合作机制公布了加快COVID-19诊断、治疗和疫苗开发与公平分配的综合投资案例。1该计划需要313亿美元投资，但目前仅获得34亿美元承诺，面临279亿美元的资金缺口，其中137亿美元为急需资金。1

按照这一计划，到2021年中期，低收入和中等收入国家将获得5亿份诊断测试和2.45亿疗程治疗。1到2021年底，全球将提供20亿剂疫苗，其中50%供应给低收入和中等收入国家。1

ACT-Accelerator以诊断、治疗、疫苗和卫生系统连接器为四大支柱开展工作，旨在加快相关工具和技术的规模化交付。1全球公民运动将于6月27日召开"Global Goal: Unite for Our Future"峰会推进落实。1

The Access to COVID-19 Tools Accelerator (ACT-Accelerator), a global collaborative mechanism under the World Health Organization, has unveiled its integrated investment case and costed plans aimed at accelerating the development, equitable distribution, and scaled delivery of COVID-19 diagnostics, therapeutics, and vaccines 1.

The initiative requires $31.3 billion in total investment to meet its objectives 1. To date, $3.4 billion has been pledged by member institutions, leaving a funding gap of $27.9 billion, with $13.7 billion identified as immediately critical 1. The ACT-Accelerator was jointly launched by the WHO Director-General, the President of France, the President of the European Commission, and the Bill & Melinda Gates Foundation in April 2020 1.

The plan sets ambitious delivery targets for low and lower-middle-income countries through mid-2021, including 500 million diagnostic tests and 245 million treatment courses 1. By the end of 2021, the initiative aims to provide 2 billion vaccine doses, with 50 percent allocated to low and lower-middle-income countries 1. The ACT-Accelerator operates across four pillars: diagnostics, therapeutics, vaccines, and health system connectors 1. A Global Goal: Unite for Our Future summit is scheduled for June 27 to advance the campaign 1.